Roger E. Susi - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Roger E. Susi has filed 5 SEC Form 4 filings across 1 company in the last 90 days - selling. Lifetime open-market sales: $14.90M.
Profile
Roger E. Susi holds the role of CEO, President, Chairman at IRADIMED CORP (IRMD). Susi has reported 28 insider filings with the SEC since 2025. The most recent filing was in June 2026.
| Role | CEO, President, Chairman, Director, 10% Owner |
|---|---|
| Notability | 55/100 |
Board memberships
- IRADIMED CORP
Reported roles
- CEO, President, Chairman
Awards & honors
- Leadership in MRI-compatible medical devices
- Development of innovative healthcare solutions
- Chairmanship at iRadimed Corp
Trading Pattern
InsiderAlpha's records for Roger E. Susi go back to 2025: 28 primary Form 4 filings, an average of 14.0 per year. 92 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Roger E. Susi has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- CEO, President, Chairman, Director, 10% Owner at IRADIMED CORP (IRMD) - 9 filings, 2026
- CEO, PRESIDENT, CHAIRMAN at IRADIMED CORP (IRMD) - 19 filings, 2025 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 924 | $91.91 | $85K |
| 2026-06-02 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 401 | $91.08 | $37K |
| 2026-06-02 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 775 | $89.79 | $70K |
| 2026-06-02 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 400 | $88.68 | $35K |
| 2026-05-28 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 333 | $92.61 | $31K |
| 2026-05-28 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 2.2K | $91.85 | $199K |
| 2026-05-28 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 1.9K | $92.93 | $176K |
| 2026-05-28 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 3.1K | $91.81 | $286K |
| 2026-05-20 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 6 | $88.65 | $532 |
| 2026-05-20 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 1.8K | $88.14 | $162K |
| 2026-05-20 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 653 | $87.13 | $57K |
| 2026-05-20 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 1.3K | $88.34 | $111K |
| 2026-05-20 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 3.5K | $87.35 | $301K |
| 2026-05-20 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 298 | $85.95 | $26K |
| 2026-05-13 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 1.1K | $84.59 | $93K |
| 2026-05-13 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 3.3K | $83.70 | $277K |
| 2026-05-13 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 315 | $85.90 | $27K |
| 2026-05-13 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 1.0K | $84.94 | $85K |
| 2026-05-13 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 1.8K | $84.08 | $149K |
| 2026-05-06 | IRMD | IRADIMED CORP | S - Open-market sale [10b5-1] | 178 | $87.31 | $16K |
Companies - Last 90 Days
- IRADIMED CORP (IRMD) - 5 filings, last 2026-06-02
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Roger E. Susi has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- John Glenn - $900K of IRMD open-market activity in the last 12 months
- Hilda Frederique Scharen-Guivel - $285K of IRMD open-market activity in the last 12 months
- James B. Hawkins - $265K of IRMD open-market activity in the last 12 months
- Monty K. Allen - $176K of IRMD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Saul B. Rosenthal
- Jack Ross
- Martine A. Rothblatt
- Saba Capital Management, L.P.
- Nicholas S. Schorsch
- Trygve Seglem
- Lawrence B. Seidman
- Thomas J. Shaw
Frequently Asked Questions
Who is Roger E. Susi?
Roger E. Susi holds the role of CEO, President, Chairman at IRADIMED CORP (IRMD). Susi has reported 28 insider filings with the SEC since 2025. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Roger E. Susi submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has Roger E. Susi been buying or selling stock?
Recorded transactions: 0 open-market purchases and 95 open-market sales ($14.90M) across all tracked filings.
Where can I see all of Roger E. Susi's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Roger E. Susi profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.